Filter By Industry
Filter By Tag

Newsroom

Tower PR Press releases

1 - 1 of 1 Press Release

Apr 28, 2016
The biotech firm oncgnostics GmbH (www.oncgnostics.com) will start distributing its molecular diagnostic test GynTect for use in cervical cancer diagnostics in an exclusive partnership with Sayre Therapeutics (www.sayretherapeutics.com).


Tower PR RSS Feed